Preview

Healthcare

Healthcare

Advanced search

Results of epidemiological surveillance in a surgical intensive care unit: a prospective single-center study

https://doi.org/10.65249/1027-7218-2026-9-35-44

Abstract

Objective. To evaluate the trends in healthcare-associated infection (HAI) rates and analyze the effectiveness of the infection control system in a surgical anesthesiology and intensive care unit (ICU) among patients undergoing abdominal surgeries and liver or kidney transplantation.

Materials and methods. A single-center prospective study was conducted at the ICU of the Minsk Scientific and Practical Center for Surgery, Transplantology and Hematology. Over the period from 2019 to 2025, a total of 10,567 patients were treated (82.2 % – surgical profile, 30.6 % – post-transplant recipients). Epidemiological surveillance included registration of HAIs using standard case definitions, microbiological monitoring, and assessment of antimicrobial resistance. Data processing was performed using WHONET 5.6 and IBM SPSS Statistics 26.0 software.

Results. The overall incidence of healthcare-associated infections (HAIs) peaked in 2021 at 12.5 (95 % CI (9.7–15.5)) per 100 patients, then decreased to 5.6 in 2022 and stabilized in 2023–2025 at 4.6–5.9 per 100 treated patients. The rate of ventilatorassociated pneumonia decreased from 27.3 (2021) to 12.8 (2025) per 1000 ventilator-days (p = 0.04). The rate of surgical site infections decreased from 1.0 (2019) to 0.5 (2025) per 100 operations (p = 0.03). A shift in the timing of late-onset infections was noted (VAP – on day 10 of mechanical ventilation, CAUTI – on day 13 of catheterization). An increase in the proportion of Gram-positive flora (from 25 to 33 %, p = 0.06) and Candida fungi (Candida non-albicans – 58%, including C. auris – 31 %) was revealed. The proportion of imported cases was 21% (95 % CI (16.7–25.9)). An increase in the susceptibility of major Gram-negative pathogens to carbapenems and polymyxins was observed (p < 0.05 for most comparisons).

Conclusion. The implementation of epidemiological surveillance, adherence to infection control measures, and optimization of antimicrobial therapy are associated with a reduction in HAI incidence and the prevalence of carbapenem-resistant microorganisms, as well as with a mitigation of the consequences of imported epidemiologically significant pathogens.

About the Authors

L. Kuzmenkova
Минский научно-практический центр хирургии, трансплантологии и гематологии
Belarus


P. Prilutsky
Минский научно-практический центр хирургии, трансплантологии и гематологии
Belarus


A. Dzyadzko
Минский научно-практический центр хирургии, трансплантологии и гематологии
Belarus


A. Shcherba
Минский научно-практический центр хирургии, трансплантологии и гематологии
Belarus


O. Rummo
Минский научно-практический центр хирургии, трансплантологии и гематологии
Belarus


References

1. Stewart S., Robertson C., Pan J., et al. Epidemiology of healthcare-associated infection reported from a hospital-wide incidence study: considerations for infection prevention and control planning. J Hosp Infect. 2021; 114: 10–22.

2. Kilgore M.L., Ghosh K., Beavers C.M., et al. The costs of nosocomial infections. Med Care. 2008; 46(1): 101–104.

3. Isigi S.S., Parsa A.D., Alasqah I., et al. Predisposing factors of nosocomial infections in hospitalized patients in the United Kingdom. JMIR Public Health Surveill. 2023; 9. doi: 10.2196/43743.

4. Ali S., Birhane M., Bekele S., et al. Healthcare associated infection and its risk factors among patients admitted to a tertiary hospital in Ethiopia. Antimicrob Resist Infect Control. 2018; 7. doi: 10.1186/s13756-017-0298-5.

5. Tacconelli E., Carrara E., Savoldi A., et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018; 18(3): 318–327.

6. Antibiotic Resistance Threats in the United States, 2019. Atlanta, GA : U.S. Department of Health and Human Services, CDC; 2019. Available at: https://www.cdc.gov/antimicrobial-resistance/media/pdfs/2019-ar-threats-report-508.pdf (accessed: 06.07.2026).

7. Surveillance of antimicrobial resistance in Europe, 2021 data / European Centre for Disease Prevention and Control. Stockholm: ECDC, 2022. Available at: https://iris.who.int/server/api/core/bitstreams/42fd72b9-a207-4659-ad4d-b6f24146ea83/content (accessed: 06.07.2026).

8. Orlova O.A., Akimkin V.G. Experience of conducting epidemiological surveillance of ventilator-associated respiratory tract infections. Epidemiologiya i infekcionnye bolezni. 2018; 23(1): 21–26. (in Russian)

9. World Health Organization. WHO fungal priority pathogens list to guide research, development and public health action. Geneva, Switzerland; 2022. Available at: https://iris.who.int/server/api/core/bitstreams/69af4379-4f27-4ac4-8973-74d7b52af7bd/content (accessed: 06.07.2026).

10. Bilal H., Shafiq M., Hou B., et al. Distribution and antifungal susceptibility pattern of Candida species from mainland China. Virulence. 2022; 13(1): 1573–1589.

11. Oganesyan E., Klimenteva V., Vybornova I., et al. Population structure based on microsatellite length polymorphism, antifungal susceptibility profile, and enzymatic activity of Candida auris clinical isolates in Russia. J Fungi (Basel). 2025; 11(1). doi: 10.3390/jof11010035.

12. Duk N.V., Shchuchinova L.Yu., Luk'yanenko N.A. Healthcare-associated infections: from the problems of morbidity registration to the modern assessment of the situation. Medicina. 2025; 4: 57–71. (in Russian)

13. Coman A., Pop D., Muresan F., et al. Surveillance and reporting of hospital-associated infections-a document analysis of Romanian healthcare legislation evolution over 20 years. Healthcare (Basel). 2025; 13(3). doi: 10.3390/healthcare13030229.


Review

For citations:


Kuzmenkova L., Prilutsky P., Dzyadzko A., Shcherba A., Rummo O. Results of epidemiological surveillance in a surgical intensive care unit: a prospective single-center study. Healthcare. 2026;1(9):35-44. (In Russ.) https://doi.org/10.65249/1027-7218-2026-9-35-44

Views: 129

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1027-7218 (Print)